Original article
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyensa,b,c,#,
, Demi P.A.van Malded,#, Gediz Dogay Usb,e, Francesco Innocentif, Mathieu Struyvec, Christophe Van Steenkisteg,h,i, Sven Francqueg,i, Geert Robaeysa, Ger H. Koekb,d, the MASLD research group †
Corresponding author
a Hasselt University, Faculty of Health and Life Sciences/LCRC, Diepenbeek, Belgium
b Maastricht University, School of Nutrition and Translational Research in Metabolism, NUTRIM, Maastricht, the Netherlands
c Ziekenhuis Oost-Limburg, Department of Gastro-enterology and Hepatology and Department Future Health, Genk, Belgium
d MUMC+, Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Netherlands,
e Pax Clinic, Department of Gastroenterology, Istanbul, Türkiye
f Department of Methodology and Statistics, Care and Public Health Research Institute (CAPHRI), Maastricht University
g Antwerp University Hospital, Department of Gastroenterology and Hepatology, Antwerp, Belgium
h AZ Maria Middelares Ghent, Department of Gastroenterology and Hepatology, Ghent, Belgium
i Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, InflaMed, University of Antwerp, Antwerp, Belgium
Ver más
